SkinnyRx Review
Online GLP-1 Weight Loss Medications
FDA action on record
FDA reviewed skinnyrx.com and stated that claims made about the compounded GLP-1 products offered there were false or misleading.
- Entity: Lean Rx, Inc. dba SkinnyRx
- Action: FDA warning letter (MARCS-CMS 717989)
- Date: February 20, 2026
A warning letter is FDA's stated position that violations occurred. It is not a court finding, a recall, or a determination that any patient was harmed, and these letters concerned marketing claims about compounded GLP-1 products rather than a specific batch of medication. Companies often respond and correct the cited material. We publish this so you can weigh it yourself — read the letter and check the provider's current status before deciding.
Read the FDA letter on fda.gov →Overview
SkinnyRx provides online access to GLP-1 weight loss medications through their telehealth platform. Their straightforward approach connects patients with providers who can prescribe appropriate weight loss treatments. With a focus on accessibility, they aim to make GLP-1 medications available to those who qualify.
Pros
- Online convenience
- GLP-1 access
- Telehealth platform
- Simple process
- Phone support available
Cons
- Limited information available
- Less established
Key Features
Best For
Those seeking basic online GLP-1 access
Quick Stats
Share Your Experience
Help others by sharing your experience with SkinnyRx
User Reviews
No ratings yet
Rate your experience
Click a star to rate and add a review
Questions & Discussions
Ready to Get Started with SkinnyRx?
Join thousands of others who have started their weight loss journey with SkinnyRx.
Visit SkinnyRx